Company WNTH AB Swiss Exchange
Equities
WNT
SE0003553130
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- SEK | - |
05-03 | WntResearch AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
02-29 | WntResearch AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Per Norlén
CEO | Chief Executive Officer | 54 | 01-09 |
Founder | 68 | 07-09-23 | |
Anders Tidfors
DFI | Director of Finance/CFO | - | 20-09-10 |
Kicki Johansson
COO | Chief Operating Officer | 66 | 17-12-31 |
Chief Tech/Sci/R&D Officer | 62 | 16-07-31 | |
Corporate Officer/Principal | 56 | 18-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 72 | 15-06-08 | |
Founder | 68 | 07-09-23 | |
Chairman | 62 | 21-12-31 | |
Gudrun Anstrén
BRD | Director/Board Member | 69 | 18-05-14 |
Director/Board Member | - | - | |
Mats Lindskog
BRD | Director/Board Member | - | 22-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 866,058,993 | 130,962,880 ( 15.12 %) | 0 | 15.12 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+9.58% | 115B | |
+12.41% | 106B | |
-2.59% | 21.96B | |
-12.38% | 21.87B | |
-5.29% | 19.21B | |
-3.35% | 18.08B | |
-38.57% | 17.71B | |
+7.51% | 14.32B | |
+35.67% | 12.42B |
- Stock Market
- Equities
- WNT Stock
- WNT Stock
- Company WNTH AB